Danish pharmaceutical giant Novo Nordisk has revised its profit forecasts downwards for the fourth time this year as competition in the slimming and diabetes treatments market continues to grow. The
Danish pharmaceutical giant Novo Nordisk has revised its profit forecasts downwards for the fourth time this year as competition in the slimming and diabetes treatments market continues to grow. The
The United Kingdom stands on the threshold of a radical transformation in obesity treatment, as Eli Lilly prepares to introduce a daily weight-loss pill, Orforglipron, in 2026, once regulatory approval
Eli Lilly, the US manufacturer of the weight management injection Mounjaro, has announced a new discount for private pharmacies in the UK. The move follows widespread concern after the company
Eli Lilly, one of the world’s largest pharmaceutical companies, has temporarily halted orders of its highly sought-after weight-loss injection, Mounjaro, to the UK. This move comes as the market braces
Eli Lilly, the pharmaceutical giant behind the popular weight loss injection Mounjaro, has announced a substantial price hike for the medication due to take effect in the UK from September.
A major rise in the cost of Mounjaro is set to impact more than a million weight loss patients across Britain next month amid an international dispute over medicine prices.
In a remarkable feat, Eli Lilly’s weight-loss drug Zepbound has surpassed 1 billion in sales for the first time, exceeding Wall Street’s expectations. The American pharmaceutical giant also saw strong






